drugset / Trial / NCT00109733
Cool.Click™ Adolescent Transition Study: Study of Saizen® in Subjects With Childhood-onset Growth Hormone Deficiency
RandomizedParallel-groupOpen-labelTreatment
Summary
The primary objective is to evaluate the efficacy and safety of two different dose regimens of r-hGH (Saizen®) in subjects with childhood-onset growth hormone deficiency (COGHD) during the transition phase from childhood to adulthood.
Timeline
- Start
- 2005-01
- Primary completion
- 2006-06
- Completion
- 2006-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Somatropin | Protein / enzyme biologic | 0.01 mg/kg | Subcutaneous |
| Subject | Somatropin | Protein / enzyme biologic | 0.03 mg/kg | Subcutaneous |